Skip to main content
SpringerLink
Log in

ASO Author Reflections: Opting for the Most Appropriate Treatment Approach for Elderly Patients with Resectable Esophageal Cancer

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Vlacich G, Samson PP, Perkins SM, et al. Treatment utilization and outcomes in elderly patients with locally advanced esophageal carcinoma: a review of the national cancer database. Cancer Med. 2017;6:2886–96.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Koeter M, van Putten M, Verhoeven RHA, Lemmens V, Nieuwenhuijzen GAP. Definitive chemoradiation or surgery in elderly patients with potentially curable esophageal cancer in the Netherlands: a nationwide population-based study on patterns of care and survival. Acta Oncol. 2018;57:1192–200.

    Article  CAS  PubMed  Google Scholar 

  3. Ji Y, Du X, Zhu W, et al. Efficacy of concurrent chemoradiotherapy with S-1 vs radiotherapy alone for older patients with esophageal cancer: a multicenter randomized phase 3 clinical trial. JAMA Oncol. 2021;7:1459–66.

    Article  PubMed  Google Scholar 

  4. Wang P, Lei M, Chen Y, et al. Prognostic factors and outcomes in elderly esophagectomy patients with esophageal cancer. Ann Surg Oncol. 2023. https://doi.org/10.1245/s10434-023-14634-6.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Yang H, Liu H, Chen Y, et al. Neoadjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of the esophagus (NEOCRTEC5010): a phase III multicenter, randomized, open-label clinical trial. J Clin Oncol. 2018;36:2796–803.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Eyck BM, van Lanschot JJB, Hulshof M, et al. Ten-year outcome of neoadjuvant chemoradiotherapy plus surgery for esophageal cancer: the randomized controlled CROSS trial. J Clin Oncol. 2021;39:1995–2004.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgment

This study was supported by the National Natural Science Foundation of China (Grant No. 82002497) and the Natural Science Foundation of Fujian Province (Grant No. 2021J01442).

Author information

Author notes

  1. Mengxia Lei and Peiyuan Wang have contributed equally to this work and share first authorship.

Authors and Affiliations

  1. Department of Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, China

    Mengxia Lei MD, PhD

  2. Department of Thoracic Oncology Surgery, Clinical Oncology School of Fujian Medical, Fujian Cancer Hospital, Fuzhou, China

    Peiyuan Wang MD, PhD, Shuoyan Liu MB & Feng Wang MD

  3. Fujian Key Laboratory of Translational Cancer Medicine, Fuzhou, China

    Peiyuan Wang MD, PhD

  4. Fujian Provincial Key Laboratory of Tumor Biotherapy, Fuzhou, China

    Peiyuan Wang MD, PhD

Authors
  1. Mengxia Lei MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peiyuan Wang MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shuoyan Liu MB
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Feng Wang MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Shuoyan Liu MB or Feng Wang MD.

Ethics declarations

Disclosure

There are no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article refers to: Wang P, Lei M, Chen Y, et al. Prognostic factors and outcomes in elderly esophagectomy patients with esophageal cancer. Ann Surg Oncol. 2023. https://doi.org/10.1245/s10434-023-14634-6.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lei, M., Wang, P., Liu, S. et al. ASO Author Reflections: Opting for the Most Appropriate Treatment Approach for Elderly Patients with Resectable Esophageal Cancer. Ann Surg Oncol 31, 2517–2518 (2024). https://doi.org/10.1245/s10434-023-14863-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-023-14863-9

Search

Navigation